Navigation Links
Pharmacyclics Reports Financial Results for Fiscal 2010 and for Fourth Quarter 2010
Date:9/13/2010

e Months EndedYear EndedJune 30,June 30,2010200920102009Revenues:  License, collaboration and milestone revenues(1)$

2,493$

-$

9,307$

-Total revenues2,493-9,307-Operating expenses:  Research and development(2)(3)6,6683,13917,35813,954  General and administrative(4)2,6861,3727,5618,474Total operating expenses9,3544,51124,91922,428Loss from operations(6,861)(4,511)(15,612)(22,428)Interest and other income (expense), net(5)(6)23(345)38(469)Loss before benefit (expense) for income taxes(6,838)(4,856)(15,574)(22,897)Benefit (expense) from Income Tax(7)-(550)550(550)Net loss$

(6,838)$

(5,406)$

(15,024)$

(23,447)Basic and diluted net loss per share$

(0.13)$

(0.20)$

(0.31)$

(0.88)Shares used to compute basic and  diluted net loss per share51,77127,53348,34426,570(1)  Includes $1,211 for the year ended June 30, 2010 related to the pro-rata portion of services performed under the Servier Collaboration arrangement prior to this fiscal year.

(2)  Includes a one time payment for the year ended June 30, 2009 of $1,000 to Celera Corporation as part of the Servier License Agreement.

(3)  Includes stock based compensation of $1,400 for three months ended June 30, 2010 and of $186 for three months ended June 30, 2009.  Includes stock based compensation of $1,998 for the year ended June 30, 2010 and of $738 for the year ended June 30, 2009.

(4)  Includes stock based compensation of $492 for three months ended June 30, 2010 and of $186 for three months ended June 30, 2009.  Includes stock based compensation of $1,192 for the year ended June 30, 2010 and of $2,555 for the year ended June 30, 2009.

(5)  Includes accrued interest expense for the three months ended June 30, 2010 and 2009, respectively, to be paid out for the loan to an affiliate of Robert W. Duggan of $0 and $52 and due to its below market interest rate the
'/>"/>

SOURCE Pharmacyclics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Pharmacyclics Announces Data and Publication Characterizing Highly-Selective HDAC Inhibitor
2. Pharmacyclics Announces Preclinical Results Supporting Development of Its Novel Btk Inhibitor in Immune Mediated Diseases
3. Pharmacyclics Reports Multiple Presentations at AACR on Its HDAC and Selective HDAC Inhibitors
4. Pharmacyclics Novel Factor VIIa Inhibitor Demonstrates Potential Inhibition of Tumor Growth in Multiple Types of Cancer
5. Pharmacyclics Novel Btk Inhibitor Shows Efficacy in Preclinical Models of Rheumatoid Arthritis and Lymphoma
6. Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483
7. Pharmacyclics, Inc. Announces Closing of a Private Financing With the Principals of Pacific Biopharma Group, Ltd.
8. Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkins Lymphoma
9. Pharmacyclics announces Global Strategic Alliance with Les Laboratoires Servier
10. Pharmacyclics to Present at Merriman Curhan Fords Investor Summit 2009
11. Pharmacyclics Announces Poster Presentations and Clinical Update at the 51st Annual Meeting of the American Society of Hematology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... , July 31, 2015  Boston Children,s Hospital ... from 3D printing of their anatomy before undergoing ... cerebrovascular malformations (abnormalities in the brain,s blood vessels) ... online today in the Journal of Neurosurgery: ... 3D printing and synthetic resins to create custom, ...
(Date:7/31/2015)... , July 31, 2015 ... decades of experience, the domestic pharmaceutical industry is strong, ... manufacture products to high international standards. One ... known is in sub-Saharan Africa: Morocco has quietly become ... South Africa . Indeed, Moroccan pharma ...
(Date:7/31/2015)... SAN DIEGO , July 31, 2015 ... Eisai Co., Ltd. (Headquarters: Tokyo , ... Halozyme Therapeutics, Inc. (Headquarters: San Diego, California ... , "NASDAQ: HALO") have signed a clinical collaboration agreement ... , "eribulin") in combination with Halozyme,s investigational drug PEGPH20 ...
Breaking Medicine Technology:3D Printing Helps Doctors Rehearse Complex Brain Procedures 23D Printing Helps Doctors Rehearse Complex Brain Procedures 33D Printing Helps Doctors Rehearse Complex Brain Procedures 4PharmaBoardroom Releases New Morocco Pharmaceuticals Report 2PharmaBoardroom Releases New Morocco Pharmaceuticals Report 3Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 2Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 3Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 5Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 6
... MAPLE GROVE, Minn., Feb. 18, 2011 Upsher-Smith Laboratories, ... previously announced recall of Jantoven® Warfarin Sodium, USP, 3 ... on the same packaging line between May 17, 2010 ... recall as a precautionary measure after a single bottle ...
... National Pharmacy Programs and Services was recognized at the J.D. ... a J.D. Power 2011 Customer Service Champion — ... this year. To qualify for inclusion on ... own industries, but also must stand out among leading brands ...
Cached Medicine Technology:Upsher-Smith Laboratories Announces Expansion of Voluntary Nationwide Recall 2Upsher-Smith Laboratories Announces Expansion of Voluntary Nationwide Recall 3Kaiser Permanente Recognized as a J.D. Power 2011 Customer Service Champion 2
(Date:8/1/2015)... ... 01, 2015 , ... Calvary Hospital today announced that it is embarking on ... goal is to bring this Torah – dating from 1880 – back to kosher ... services. , Scroll No. 515, from the town of Taus-Domazlice, is on permanent ...
(Date:8/1/2015)... ... August 01, 2015 , ... Brig and Lita Hart, icons of the ... of their Healthy Home mission with the HOPE Movement of EvolvHealth. In what has ... both companies have agreed to join their missions of purpose together to change the ...
(Date:8/1/2015)... York, NY (PRWEB) , ... August 01, 2015 , ... ... Vine cyberespionage group , who are thought to have been behind the attack on ... the topics covered were zero day exploits, watering hole attacks and spear phishing campaigns. ...
(Date:8/1/2015)... ... August 01, 2015 , ... BeverlyD, owner and founder of BeverlyD Luxe Organic ... very first small business donation to kick off the campaign for healing and Well-Being. ... legacy includes a complete line of raw, organic hair care products, as well as ...
(Date:8/1/2015)... ... , ... On March 19, 2015 Phil Valentine – the Executive Director of Connecticut Community for ... by stepping off Springer Mountain and heading north. Since that day, Phil has hiked over ... was greeted by friends and family. He visited CCAR and left an inspirational message ...
Breaking Medicine News(10 mins):Health News:Calvary Hospital Announces Plans to Restore Historic Torah 2Health News:Calvary Hospital Announces Plans to Restore Historic Torah 3Health News:Looking for HOPE? Healthy Home Has Evolv’d 2Health News:Looking for HOPE? Healthy Home Has Evolv’d 3Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 2Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 3Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 4Health News:March4thforWellBeing Foundation Kickoff 2Health News:Connecticut Executive Hikes Appalachian Trail to Raise Awareness About Recovery. 2
... DANVILLE, PA Using the Electronic Health Record to ... in improved blood sugar and cholesterol levels, better vaccination ... new Geisinger study. , Geisinger Health System launched ... diabetes patients in 2005. A study published in Aprils ...
... Across the Country Gather to Discuss, Interactive Patient Care Topics ... ... Patient Experience, WASHINGTON, April 7, 2008 ... solutions, today,announced the kick-off of GetConnected2008. Designed exclusively for the,GetWellNetwork ...
... New York Hospital Upgrades Three X-Ray Rooms from Film to IDC ... ... April 7 /PRNewswire-FirstCall/ - IDC (Imaging Dynamics Company,Ltd.) (TSX: IDL), the ... that Saratoga Hospital in Saratoga,Springs, New York has purchased IDC,s X2200, ...
... The critical lack of,family and paraprofessional caregivers ... renewal of the Community College Caregiver Training,Initiative for ... Foundation, The Caregiving Project for Older,Americans, a project ... a Request for Proposals (RFP) and will award ...
... DNA Day on April 25th, Suracell Inc. urges Americans to use ... their genes to promote healthy aging, SOUTH ... stock up on everything touted as "good for you?" Convinced,there,s nothing you ... the pioneer in personal genetic health. With National DNA,Day on April 25, ...
... has significantly advanced understanding of the molecular events ... in adults, human glioblastoma (GBM). The research, published ... the journal Cancer Cell, validates known genetic aberrations ... thereby elucidating new directions for potential therapeutic strategies. ...
Cached Medicine News:Health News:Geisinger improves care for thousands of diabetics through use of the Electronic Health Record 2Health News:GetWellNetwork Kicks Off GetConnected2008, First Annual Users Conference 2Health News:GetWellNetwork Kicks Off GetConnected2008, First Annual Users Conference 3Health News:Saratoga Hospital Purchases Three IDC DR Systems 2Health News:Saratoga Hospital Purchases Three IDC DR Systems 3Health News:ILC-USA and MetLife Foundation Launch Second Year of Community College Caregiver Training Grants 2Health News:Know Your Personal Genetic Health to Age Better Now! 2Health News:New regulatory circuit identified for aggressive, malignant brain tumor 2
This multiple-function instrument allows the surgeon to grasp, coagulate, and transect tissue with a single instrument, eliminating the need for multiple instruments and, in some procedures, costly l...
Bipolar forceps...
... An in vitro Nucleic Acid ... using Microplate Chemiluminescence for the ... (HPV) Types 6,11,16,18,31,33,35,39,42,43,44,45,51,52,56,58,59 and 68 ... Lowand High-Risk Groups in Cervical ...
... superb radiation protection-0.62mm (+/- .05)Pb lead glass ... to their level of protection, they are ... smoothly on your bridge while hugging your ... wear corrective lenses, you can order Leaded ...
Medicine Products: